Literature DB >> 12110413

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting.

P Qvist1, S Christgau, B J Pedersen, A Schlemmer, C Christiansen.   

Abstract

We examined the diurnal variation in serum concentration of C-terminal telopeptide of type I collagen (serum CrossLaps, sCTx) under various conditions. The studies included a total of 100 individuals. Blood samples were collected every 3 h over 27 h. sCTx levels varied over the 24 h with a maximum at about 05:00 in the morning and a minimum of about 14:00 in the afternoon. The variation had a magnitude of about +/-40% around the 24 h mean and was similar in premenopausal and early and late postmenopausal women with normal and low bone mass. Furthermore, it was not affected by 5 days of bed-rest, by absence of a normal diurnal variation in cortisol production, or by absence of a normal light cycle (blindness). Nasal salmon calcitonin, an antiresorptive drug used for treatment of osteoporosis, was not able to break the circadian pattern whether the treatment was administered in the morning or the evening. The only parameter that showed a pronounced influence on the circadian variation was fasting, which reduced the variation significantly to about one fourth. From a practical point of view the results of this study demonstrate that samples for sCTx should be taken in the fasting state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110413     DOI: 10.1016/s8756-3282(02)00791-3

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  89 in total

Review 1.  Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

Authors:  J J Stepan
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

Review 2.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 3.  The skeletal subsystem as an integrative physiology paradigm.

Authors:  Aaron J Weiss; Jameel Iqbal; Neeha Zaidi; Jeffrey I Mechanick
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

4.  Acute effects of plyometric jumping and intermittent running on serum bone markers in young males.

Authors:  Che-Fu Lin; Tsang-hai Huang; Kuo-Cheng Tu; Linda L Lin; Yi-Hsuan Tu; Rong-Sen Yang
Journal:  Eur J Appl Physiol       Date:  2011-08-12       Impact factor: 3.078

Review 5.  Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.

Authors:  Serge Cremers; Patrick Garnero
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 6.  Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

Authors:  Aubrey Blumsohn
Journal:  Curr Osteoporos Rep       Date:  2003-12       Impact factor: 5.096

Review 7.  An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice.

Authors:  D J Leeming; P Alexandersen; M A Karsdal; P Qvist; S Schaller; L B Tankó
Journal:  Eur J Clin Pharmacol       Date:  2006-08-16       Impact factor: 2.953

8.  Effect of increased fruit and vegetable consumption on bone turnover in older adults: a randomised controlled trial.

Authors:  C E Neville; I S Young; S E C M Gilchrist; M C McKinley; A Gibson; J D Edgar; J V Woodside
Journal:  Osteoporos Int       Date:  2013-05-29       Impact factor: 4.507

9.  Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate.

Authors:  Joy N Tsai; Yuli Zhu; Katelyn Foley; Hang Lee; Sherri-Ann Burnett-Bowie; Robert M Neer; Benjamin Z Leder
Journal:  J Clin Endocrinol Metab       Date:  2015-05-01       Impact factor: 5.958

Review 10.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:  Matthew B Greenblatt; Joy N Tsai; Marc N Wein
Journal:  Clin Chem       Date:  2016-12-09       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.